The necessity and impact of SARS-CoV2 on the world's health have led to developing and producing practical and useful vaccines for this deadly respiratory virus. Since April 2020, a vaccine for the virus has been developed. Given that comorbidities such as diabetes, hypertension, and cardiovascular disease are more prone to viruses and the risk of infection, vaccines should be designed to protect against high-risk respiratory illnesses. Including SARS, MERS, influenza, and the SARS-CoV-2 provide a safe immune response. Here, we review the information and studies that have been done to help develop strategies and perspectives for producing a safe and ideal vaccine to prevent COVID-19 in normal people, especially at high-risk groups such as diabetes patients.

中文翻译：

---

对 COVID-19 疫苗的回顾和糖尿病患者的主要考虑因素

SARS-CoV2 对世界健康的必要性和影响已导致为这种致命的呼吸道病毒开发和生产实用且有用的疫苗。自 2020 年 4 月以来，已经开发出一种针对该病毒的疫苗。鉴于糖尿病、高血压和心血管疾病等合并症更容易感染病毒和感染风险，因此应设计疫苗以预防高危呼吸道疾病。包括 SARS、MERS、流感和 SARS-CoV-2 提供了安全的免疫反应。在这里，我们回顾了已经完成的信息和研究，以帮助制定战略和观点，以生产安全和理想的疫苗，以预防正常人群中的 COVID-19，尤其是糖尿病患者等高危人群。